Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms. [electronic resource]
Producer: 20070604Description: 194-200 p. digitalISSN:- 0009-9120
- Adult
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Angiotensinogen -- genetics
- Cross-Over Studies
- Enalapril -- administration & dosage
- Female
- Humans
- Kidney Transplantation
- Lipid Peroxidation -- drug effects
- Losartan -- administration & dosage
- Male
- Malondialdehyde -- blood
- Peptidyl-Dipeptidase A -- genetics
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Receptor, Angiotensin, Type 1 -- genetics
- Renin-Angiotensin System -- genetics
- Sequence Analysis, DNA
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.